Identification of best outreach strategies and delivery modalities for population subgroups for COVID-19 vaccination.

Saved in:
Bibliographic Details
Title: Identification of best outreach strategies and delivery modalities for population subgroups for COVID-19 vaccination.
Authors: Caburnay CA; Health Communication Research Laboratory, Brown School, Washington University in St. Louis, MSC 1196-0251-46, One Brookings Drive, St. Louis, MO 63130, USA. Electronic address: ccaburnay@wustl.edu., Fu QJ; Department of Community Health, School of Arts and Sciences, Tufts University, 574 Boston Ave., Medford, MA 02155, USA. Electronic address: John.fu@tufts.edu., Carter T; Health Communication Research Laboratory, Brown School, Washington University in St. Louis, MSC 1196-0251-46, One Brookings Drive, St. Louis, MO 63130, USA. Electronic address: carter.tyla@wustl.edu., Butler T; Health Communication Research Laboratory, Brown School, Washington University in St. Louis, MSC 1196-0251-46, One Brookings Drive, St. Louis, MO 63130, USA. Electronic address: butler.t@wustl.edu., Broadus DE; Saint Louis County Department of Public Health, 6121 N. Hanley Rd., Berkeley, MO 63134, USA. Electronic address: DBroadus@stlouiscountymo.gov., Davis MH; City of St. Louis Department of Health, 1520 Market St., Rm. 4051, St. Louis, MO 63103-2626, USA. Electronic address: docmati82@gmail.com., Kreuter MW; Health Communication Research Laboratory, Brown School, Washington University in St. Louis, MSC 1196-0251-46, One Brookings Drive, St. Louis, MO 63130, USA. Electronic address: mkreuter@wustl.edu.
Source: Vaccine [Vaccine] 2026 May 19; Vol. 60 Suppl 1, pp. 128721. Date of Electronic Publication: 2026 May 19.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2026.128721